Asker Muntecep, Asker Selvi, Kucuk Ugur, Kucuk Hilal Olgun
Department of Cardiology, Van Education and Research Hospital, Van, Turkey.
Department of Chest Disease, Van Education and Research Hospital, Van, Turkey.
Clinics (Sao Paulo). 2014 Nov;69(11):731-4. doi: 10.6061/clinics/2014(11)04.
Upper airway resistance syndrome is a sleep-disordered breathing syndrome that is characterized by repetitive arousals resulting in sympathetic overactivity. We aimed to determine whether upper airway resistance syndrome was associated with poorly controlled hypertension.
A total of 40 patients with resistant hypertension were enrolled in the study. All of the patients underwent polysomnographic examinations and 24-hour ambulatory blood pressure monitoring to exclude white coat syndrome and to monitor treatment efficiency. Among 14 upper airway resistance syndrome patients, 2 patients had surgically correctable upper airway pathologies, while 12 patients were given positive airway pressure therapy.
All patients underwent polysomnographic examinations; 22 patients (55%) were diagnosed with obstructive sleep apnea and 14 patients (35%) were diagnosed with upper airway resistance syndrome, according to American Sleep Disorders Association criteria. The patients with upper airway resistance syndrome were younger and had a lower body mass index compared with other patients, while there were no difference between the blood pressure levels and the number of antihypertensive drugs. The arousal index was positively correlated with systolic blood pressure level (p=0.034; rs=0.746), while the Epworth score and AHI were independent of disease severity (p=0.435, rs=0.323 and p=0.819, rs=-0.097, respectively). Eight patients were treated with positive airway pressure treatment and blood pressure control was achieved in all of them, whereas no pressure reduction was observed in four untreated patients.
We conclude that upper airway resistance syndrome is a possible secondary cause of resistant hypertension and that its proper treatment could result in dramatic blood pressure control.
上气道阻力综合征是一种睡眠呼吸障碍综合征,其特征为反复觉醒导致交感神经过度活跃。我们旨在确定上气道阻力综合征是否与高血压控制不佳有关。
本研究共纳入40例顽固性高血压患者。所有患者均接受多导睡眠图检查和24小时动态血压监测,以排除白大衣综合征并监测治疗效果。在14例上气道阻力综合征患者中,2例患者存在可通过手术纠正的上气道病变,而12例患者接受了气道正压通气治疗。
所有患者均接受了多导睡眠图检查;根据美国睡眠障碍协会标准,22例患者(55%)被诊断为阻塞性睡眠呼吸暂停,14例患者(35%)被诊断为上气道阻力综合征。与其他患者相比,上气道阻力综合征患者更年轻,体重指数更低,而血压水平和抗高血压药物数量之间没有差异。觉醒指数与收缩压水平呈正相关(p = 0.034;rs = 0.746),而爱泼沃斯嗜睡量表评分和呼吸暂停低通气指数与疾病严重程度无关(分别为p = 0.435,rs = 0.323和p = 0.819,rs = -0.097)。8例患者接受了气道正压通气治疗,所有患者血压均得到控制,而4例未治疗患者未观察到血压下降。
我们得出结论,上气道阻力综合征是顽固性高血压的一个可能的继发原因,对其进行适当治疗可显著控制血压。